Article
NR0B2 Is a Key Factor for Gastric Diseases: A GEO Database Analysis Combined with Drug-Target Mendelian Randomization.
Genes - 16 Sept 2024
Li Zhengwen, Xu Lijia, Huang Dongliang, Li Chujie, Haenen Guido R M M, Zhang Ming
Abstract excerpt
Small Heterodimer Partner (SHP; NR0B2) is an orphan receptor that acts as a transcriptional regulator, controlling various metabolic processes, and is a potential therapeutic target for cancer. Examining the correlation between the expression of NR0B2 and the risk of gastric diseases could open a new path for treatment and drug development. The Gene Expression Omnibus (GEO) database was utilized to explore NR0B2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
